Cumberland Pharmaceuticals (CPIX) Tops Q1 EPS by 3c

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q1 EPS of $0.03, $0.03 better than the analyst estimate of $0.00. Revenue for the quarter came in at $11.2 million versus the consensus estimate of $9.19 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• L3Harris CEO steps down amid conduct review, shares drop
• The LGL Group (LGL) Misses Q2 EPS by 8c